FDA Clearance Tracker · K191396
Yumizen C1200 Calcium AS, Yumizen C1200 Creatinine Jaffe
Last checked: Nov 20, 2026Latest source record: Jul 26, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jul 26, 2019
Substantially Equivalent
Time to decision
63 days
Received May 24, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K191396
- Device name
- Yumizen C1200 Calcium AS, Yumizen C1200 Creatinine Jaffe
- Applicant
- HORIBA ABX SAS
- Applicant location
- Montpellier Cedex 4, FR
- Received
- May 24, 2019
- Decided
- Jul 26, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Azo Dye, Calcium (CJY)
- Device class
- Class II
- Regulation
- 21 CFR 862.1145
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CJY. The earliest in FDA's data is K761029, decided Nov 30, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K191396
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for HORIBA ABX SAS
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Yumizen H550510(k)
K260781 · Decided Sep 14, 2026 · 188 days after receipt
Device type: Counter, Differential Cell (GKZ) · Laboratory Medicine & Pathology
- Yumizen H2500510(k)
K232946 · Decided May 21, 2024 · 244 days after receipt
Device type: Counter, Differential Cell (GKZ) · Laboratory Medicine & Pathology
K193649 · Decided May 10, 2021 · 497 days after receipt
Device type: Enzymatic Method, Creatinine (JFY) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.